The FDA made good on promises to provide more clarity and transparency in the agency’s 510(k) medical device review process with a new draft guidance issued at the end of the year.
The draft guidance details the watchdog agency’s expectations for 510(k) submissions, including a crowd-pleasing flowchart meant to help device makers determine whether they’ve met standards for demonstrating that their new product equivalency with an existing device.